3D genome alterations and editing in pathology.
Autor: | Tiukacheva EA; CNRS UMR9018, Institut Gustave Roussy, 94805 Villejuif, France; Institute of Gene Biology, Moscow 119334, Russia; Moscow Institute of Physics and Technology, Moscow 141700, Russia; Faculty of Biology, Lomonosov Moscow State University, Moscow 119991, Russia; Koltzov Institute of Developmental Biology, Moscow 119334, Russia., Ulianov SV; Institute of Gene Biology, Moscow 119334, Russia; Faculty of Biology, Lomonosov Moscow State University, Moscow 119991, Russia., Karpukhina A; CNRS UMR9018, Institut Gustave Roussy, 94805 Villejuif, France; Koltzov Institute of Developmental Biology, Moscow 119334, Russia., Razin SV; Institute of Gene Biology, Moscow 119334, Russia; Faculty of Biology, Lomonosov Moscow State University, Moscow 119991, Russia., Vassetzky Y; CNRS UMR9018, Institut Gustave Roussy, 94805 Villejuif, France; Koltzov Institute of Developmental Biology, Moscow 119334, Russia. Electronic address: yegor.vassetzky@cnrs.fr. |
---|---|
Jazyk: | angličtina |
Zdroj: | Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2023 Apr 05; Vol. 31 (4), pp. 924-933. Date of Electronic Publication: 2023 Feb 08. |
DOI: | 10.1016/j.ymthe.2023.02.005 |
Abstrakt: | The human genome is folded into a multi-level 3D structure that controls many nuclear functions including gene expression. Recently, alterations in 3D genome organization were associated with several genetic diseases and cancer. As a consequence, experimental approaches are now being developed to modify the global 3D genome organization and that of specific loci. Here, we discuss emerging experimental approaches of 3D genome editing that may prove useful in biomedicine. Competing Interests: Declaration of interests The authors declare no competing interests. (Copyright © 2023 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |